The study corroborates findings from research published earlier this year showing that high levels of lutein and zeaxanthin were each associated with an approximately 40% reduction in the risk of cataract.

This research further highlights the critical role played by lutein and zeaxanthin in promoting eye health.

Click here to read more.

Right eye has developed cataracts to the point of cloudy vision.  Left eye has a cataract also, but as the transplant surgery was only 3 weeks or so ago and so that eye is still healing and vision can’t be measured.

My question is:  can cataract surgery be performed after someone has had corneal transplants?  If so, what are the possible negatives in this situation? Will it prevent in any way future corneal transplants as they become necessary? Let me add that after right eye surgery the vision was crystal clear with a contact lens – but recently vision quickly degraded due to aggressive cataract.

We are advised by ophthalmologist that this aggressive and fast growing cataract issue was caused by the steroids/anti rejection drops.

The participants in the study had been born with a rare cataract disorder in both eyes that required surgery and corrective contacts. All were deprived of normal vision as infants between three and 10 months. As these children grew to adults, their vision improved but never reached 20/20, and they showed some deficits in face perception, sharpness, direction of motion, peripheral and binocular vision.

In the study, six patients between the ages of 19 and 31 were tracked for a period of one month, in which they played the Electronic Arts (EA) videogame “Medal of Honor” for no more than two hours a day, five days a week. Five of the six showed improvement in their vision, each moving closer to 20/20 from baseline ranges of 20/32 to 20/100, with improved ability to recognize faces, see small print and judge the direction of moving dots.

Click here and here to read further details.

Dr. Jose L. Guell, MD, the leader of the study, further suggested that the high degree of control available with femtosecond lasers may enable physicians to improve the final lens position.

Meanwhile, late last month, OptiMedica Corp. announced the launch of its Catalys Precision Laser System in the United States, with the first patient cases performed by Drs. Mike and Paul Mann at the Mann Eye Institute in Houston. The system was cleared for market by the U.S. Food and Drug Administration in late December 2011.

Drs. Mann are now using Catalys to perform laser capsulotomy and lens fragmentation during cataract surgery. Findings published in the peer-reviewed publications Journal of Cataract & Refractive Surgery and Science Translational Medicine have demonstrated the system’s ability to deliver industry-leading improvement in precision and accuracy across these steps, with incision accuracy results measured in tens of microns. Laser lens fragmentation with Catalys has also been shown to greatly improve the ease and gentleness of lens disassembly, reducing cumulative dissipated energy (CDE) during ultrasound phacoemulsification by approximately 40 percent.